Homepage
Medication Guide
Indications for Ramucirumab
Ramucirumab is a targeted drug for the treatment of specific types of cancer, and its indications, applicable populations and possible adverse reactions are the focus of attention of patients and thei...
502
Thursday, June 26th, 2025, 14:41
What are the common side effects of Mobocertinib?
Mobocertinib has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (...
511
Thursday, June 26th, 2025, 14:21
Precautions for Mobocertinib Use
Mobocertinib is a drug that is commonly used to treat lung cancer, but there are some important things that patients need to be aware of when using it. Patients must use Mobocertinib strictl...
518
Thursday, June 26th, 2025, 14:19
The efficacy and effects of Mobocertinib
Mobocertinib is the first specially designed oral TKI that selectively targets EGFR exon 20 insert mutations, which obtains selectivity by targeting proteins near the α-C-helix, and exerts anti-tumor ...
508
Thursday, June 26th, 2025, 14:16
What is the therapeutic effect of Mobocertinib(Exkivity)?
Mobocertinib(Exkivity) is an innovative targeted therapy designed for patients with non-small cell lung cancer (NSCLC), particularly those harboring epidermal growth factor receptor (EGFR) exon 20 ins...
513
Thursday, June 26th, 2025, 13:47
Can Mobocertinib be taken long-term?
Mobocertinib is a drug commonly used to treat malignancies such as lung cancer. It is a tyrosine kinase inhibitor that inhibits tumor growth and spread by inhibiting specific signaling pathways. ...
502
Thursday, June 26th, 2025, 13:07
What are the dosing guidelines for Mobocertinib?
Mobocertinib is a widely used drug in the treatment of lung cancer, and its efficacy has been widely recognized. However, in order to ensure that patients are able to use Mobocertinib safely...
513
Thursday, June 26th, 2025, 11:52
Guidelines for the use of Mobocertinib
Mobocertinib is a targeted therapy for non-small cell lung cancer (NSCLC) that targets specific genetic mutations, developed by Takeda Pharmaceutical of Japan. It is mainly used for the treatment of p...
505
Thursday, June 26th, 2025, 11:32
Who is Mobocertinib suitable for?
Mobocertinib, as an innovative targeted therapy drug, provides a new treatment option for patients with non-small cell lung cancer. This article will provide more comprehensive information to physicia...
509
Thursday, June 26th, 2025, 11:18
Mechanism of action of Mobocertinib
Mobocertinib is a tyrosine kinase inhibitor used to treat certain types of cancer. As a targeted therapy, Mobocertinib exhibits significant anti-tumor activity by inhibiting the signaling pathways of ...
508
Thursday, June 26th, 2025, 11:04
206 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved